SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 43 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,000 | -62.5% | 11,235 | -43.1% | 0.00% | – |
| Q1 2020 | $8,000 | -74.2% | 19,735 | -78.2% | 0.00% | – |
| Q4 2019 | $31,000 | +138.5% | 90,735 | +386.9% | 0.00% | – |
| Q3 2019 | $13,000 | -27.8% | 18,635 | -24.0% | 0.00% | – |
| Q2 2019 | $18,000 | -10.0% | 24,535 | +51.1% | 0.00% | – |
| Q1 2019 | $20,000 | +185.7% | 16,235 | -4.1% | 0.00% | – |
| Q4 2018 | $7,000 | -82.5% | 16,935 | -15.6% | 0.00% | – |
| Q3 2018 | $40,000 | -2.4% | 20,069 | +3.1% | 0.00% | – |
| Q2 2018 | $41,000 | – | 19,469 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,133,583 | $4,104,000 | 3.61% |
| GREAT POINT PARTNERS LLC | 1,537,873 | $5,567,000 | 1.14% |
| BVF INC/IL | 1,392,720 | $5,042,000 | 1.01% |
| Boxer Capital, LLC | 525,000 | $1,901,000 | 0.74% |
| Vivo Capital, LLC | 500,000 | $1,810,000 | 0.60% |
| Healthcare Value Capital, LLC | 150,000 | $543,000 | 0.58% |
| Cormorant Asset Management, LP | 1,000,000 | $3,620,000 | 0.49% |
| Telemetry Investments, L.L.C. | 120,807 | $437,000 | 0.25% |
| Palo Alto Investors LP | 1,162,473 | $4,208,000 | 0.24% |
| NEA Management Company, LLC | 1,298,274 | $4,700,000 | 0.19% |